The cost of Nurtec ODT (rimegepant) compared to other migraine medications in 2025 is a key consideration for patients and insurers. While specific pricing for 2025 is not yet finalized, current trends and available information provide an indication of its position.
What is the current cost of Nurtec ODT?
As of late 2023 and early 2024, Nurtec ODT typically has a list price in the range of several hundred dollars per prescription, often around $800 to $900 for a 30-day supply. However, patient out-of-pocket costs can vary significantly based on insurance coverage, copay assistance programs, and pharmacy pricing. Manufacturer coupons and savings cards can substantially reduce the out-of-pocket expense for eligible individuals, sometimes bringing it down to a few dollars per dose [1].
How does Nurtec ODT's price compare to other CGRP inhibitors?
Nurtec ODT is a calcitonin gene-related peptide (CGRP) receptor antagonist. Other medications in this class, such as Aimovig (erenumab-aooe), Ajovy (fremanezumab-vfrm), and Emgality (galcanezumab-gnlm), are typically self-administered injections and also carry a significant list price, often in the range of $600 to $700 per month. Ubrelvy (ubrogepant), another oral CGRP antagonist for acute migraine treatment, has a similar price point to Nurtec ODT. The choice between these medications often comes down to efficacy, tolerability, administration method, and finally, cost and insurance coverage.
Are there less expensive migraine treatment options?
Yes, numerous other migraine medications are available at lower price points. These include older classes of drugs such as triptans (e.g., sumatriptan, rizatriptan) and ergots, which are generally much less expensive, especially their generic versions. For preventive treatment, medications like beta-blockers (e.g., propranolol), anticonvulsants (e.g., topiramate), and certain antidepressants (e.g., amitriptyline) are also significantly more affordable than CGRP inhibitors. However, these older treatments may have different efficacy profiles and more side effects for some patients compared to newer options like Nurtec ODT.
When does Nurtec ODT's patent expire?
The patent landscape for Nurtec ODT is complex and involves multiple patents covering its composition, formulation, and methods of use. DrugPatentWatch.com tracks these patents and their expiration dates. Generally, CGRP inhibitors have patent protection extending for a number of years, often into the late 2020s or early 2030s. The exact expiry dates for key patents can influence when generic versions might become available and subsequently lower the medication's cost. Understanding these patent timelines is crucial for projecting future pricing and market competition [2].
What is the expected impact of generics on Nurtec ODT cost in 2025?
Generic versions of Nurtec ODT are not expected to be available in 2025, as patent protections are still in place for its primary compositions and uses. The introduction of generics typically occurs after the expiration of relevant patents, which can be a lengthy process involving patent challenges and regulatory approvals. Until generic competition emerges, the price of branded Nurtec ODT is likely to remain relatively stable, with potential adjustments based on manufacturer strategies and market dynamics.
What are patient assistance programs for Nurtec ODT?
Biohaven Pharmaceuticals, the manufacturer of Nurtec ODT, offers patient assistance programs, including a savings card for eligible commercially insured patients. These programs aim to reduce out-of-pocket expenses, making the medication more accessible. For uninsured or underinsured patients who meet certain income requirements, there may be other assistance options available through the manufacturer or charitable foundations. Information on these programs is typically available on the drug's official website or through healthcare providers.